Indiana University School of Medicine, the Indiana University Simon Cancer Center and Indiana University Precision Health Initiative (PHI) seeks to recruit faculty with a breast cancer-focused research program. Precision Health Initiative was created with the bold goal of addressing major and large-scale health problems facing humanity through multidisciplinary teams of outstanding, innovative researchers. Precision Health was selected as the first recipient of funding from Indiana University Grand Challenges Program that is a $300 million research expansion across the entire University. The $120 million investment in Precision Health will be leveraged to recruit approximately 40 new, full-time faculty members on the Indiana University campuses in Bloomington and Indianapolis. Precision Health has supported the creation of new facilities, centers, and user platforms, including new gene editing and sequencing cores at the IUSM, and a Good Manufacturing Practice Cell Therapy (GMP) facility to produce cellular therapeutics. This investment will be leveraged with other IUSM resources to significant expand the scope of this initiative. Genomic Medicine is one of the specific areas that will be supported with substantial resources to build programs. This is an opportunity to create a vision for research and clinical implementation of genomic medicine across one of the largest health systems in the nation.
As one of the leading academic cancer research centers in the US, the Indiana University Simon Cancer Center (IUSCC) is Indiana's only National Cancer Institute (NCI)-designated cancer center that provides patient care and fosters multidisciplinary cancer research programs. The IUSCC puts significant resources into supporting research projects, developing faculty and expanding facilities that will lead to better approaches to prevention, diagnosis and treatment of cancer. Basic and physician scientists in the center have made significant discoveries that have changed the way doctors treat testicular cancer, breast cancer, gastrointestinal cancer, genitourinary cancer, leukemia, multiple myeloma, thymoma and thymic carcinomas, and thoracic cancer. The Vera Bradley Foundation Center for Breast Cancer Research within the Simon Cancer Center is focused on dramatically improving therapies for some of the most difficult-to-treat types of breast cancer, such as triple-negative breast cancer. To address clinical needs and challenges in precision cancer genomics and medicine focused in the area of breast cancer, the Genomic Medicine cluster will look for cancer research expertise in interactive cancer omics, targeted cancer therapy, cancer immunotherapy, liquid cancer biopsy, molecular metabolomics, adult solid tumors and precision cancer treatment.
Maintain and expand a strong, extramurally funded, breast cancer-focused research program
Assist in training next generation of breast cancer researchers
Ample opportunities for research and collaboration, including:
The Center for Medical Genomics at IUSM, a state-of-the-art technology center that provides medical scientists with affordable access to high-quality high-throughput genomics services
Genome Services Facility (GSF) that provides consulting and services for the generation of sequencing libraries and next-generation sequencing
The Brown Center for Immunotherapy at IUSM, established with $30 million gift from Dr. Don Brown
The Center for Computational Biology and Bioinformatics that supports advanced computation and informatics analyses to promote cancer research and drug development.
Indiana University is an Equal Opportunity, Affirmative Action employer committed to building a building a diverse learning environment and on supporting the professional development of ethnic minorities, women, and people with disabilities. All qualified applicants will receive consideration for employment without regard to age, color, disability, ethnicity, sex, gender identity, gender expression, genetic information, marital status, national origin, race, religion, sexual orientation, or veteran status.
MD, PhD, or equivalent experience
National reputation in breast cancer with a record of scholarship in the discipline and evidence of excellence
Rising stars who have demonstrated unusual talent and a rapid upward trajectory
Department Contact for Questions:
Senem Guler email@example.com
OAA #: IUSM004542016
Internal Number: 6707
About Indiana University
Founded in 1820, Indiana University is the state’s public university system, comprised of two core campuses—IU-Bloomington and IUPUI—and six regional campuses located throughout the state. Combined, the total student population is more than 114,000 undergraduate, graduate and professional school students. IU is one of the largest employers in the state, with over 20,000 faculty and staff. Indiana University is an equal employment and affirmative action employer and a provider of ADA services. Diversity and inclusion remains a core commitment to IU’s mission to cultivate an educational environment that supports equal access, participation and representation on all of its campuses and that provides educational and career opportunities for all.